Related references
Note: Only part of the references are listed.Dose dependent development of diabetes mellitus and non-alcoholic steatohepatitis in monosodium glutamate-induced obese mice
Yoshiyuki Sasaki et al.
LIFE SCIENCES (2009)
Recent advances in metabolic syndrome and cardiovascular disease
Louis Guize et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2008)
The Metabolic Syndrome
Marc-Andre Cornier et al.
ENDOCRINE REVIEWS (2008)
Evidence-based efficacy of Kampo formulas in a model of non alcoholic fatty liver
Makoto Fujimoto et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2008)
Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis
Guruprasad P. Aithal et al.
GASTROENTEROLOGY (2008)
Regulatable Fatty Acid Transport Mechanisms Are Central to the Pathophysiology of Obesity, Fatty Liver, and Metabolic Syndrome
Paul D. Berk
HEPATOLOGY (2008)
Monosodium glutamate (MSG): A villain and promoter of liver inflammation and dysplasia
Yuko Nakanishi et al.
JOURNAL OF AUTOIMMUNITY (2008)
Adipocytokines and liver disease
Yoshihiro Kamada et al.
JOURNAL OF GASTROENTEROLOGY (2008)
Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice
I. Murano et al.
JOURNAL OF LIPID RESEARCH (2008)
The effect of hyperbaric oxygen therapy on blood vessel function in diabetes mellitus
Sanela Unfirer et al.
MEDICAL HYPOTHESES (2008)
Effects of Weight Loss on Nonalcoholic Fatty Liver Disease
Nila Rafiq et al.
SEMINARS IN LIVER DISEASE (2008)
Adipocyte death, adipose tissue remodeling, and obesity complications
Katherine J. Strissel et al.
DIABETES (2007)
Pathology of nonalcoholic fatty liver disease
Matthew M. Yeh et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
Pioglitazone treatment increases whole body fat but not total body water in patients with non-alcoholic steatohepatitis
Bogdan Balas et al.
JOURNAL OF HEPATOLOGY (2007)
Intracellular balance of oxidative stress and cytoprotective molecules in damaged interlobular bile ducts in autoimmune hepatitis and primary biliary cirrhosis:: In situ detection of 8-hydroxydeoxyguanosine and glutathione-S-transferase-pi
Yoshiko Kadokawa et al.
HEPATOLOGY RESEARCH (2007)
Apoptosis of T-leukemia and B-myelorna cancer cells induced by hyperbaric oxygen increased phosphorylation of p38 MAPK
Yen-Chen Chen et al.
LEUKEMIA RESEARCH (2007)
Differential effect of dietary antioxidant classes (carotenoids, polyphenols, vitamins C and E) on lutein absorption
Emmanuelle Reboul et al.
BRITISH JOURNAL OF NUTRITION (2007)
Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition
Matthew Cave et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2007)
Hyperbaric exposure with high oxygen concentration inhibits growth-associated increase in the glucose level of diabetic Goto-Kakizaki rats
K. Yasuda et al.
DIABETES OBESITY & METABOLISM (2006)
Influences of hyperbaric oxygen on blood pressure, heart rate and blood glucose levels in patients with diabetes mellitus and hypertension
Noori S. Al-Waili et al.
ARCHIVES OF MEDICAL RESEARCH (2006)
Hyperbaric oxygen therapy in orthopedic conditions: An evaluation of safety
Kuo-Chin Huang et al.
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE (2006)
Type 2 diabetes meffitus in obese mouse model induced by monosodium glutamate
M Nagata et al.
EXPERIMENTAL ANIMALS (2006)
Nonalcoholic fatty liver disease: From steatosis to cirrhosis
GC Farrell et al.
HEPATOLOGY (2006)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Early hyperbaric oxygen therapy attenuates disease severity in lupus-prone autoimmune (NZB x NZW) F1 mice
SY Chen et al.
CLINICAL IMMUNOLOGY (2003)
The role of hyperbaric oxygen therapy in sports medicine
S Babul et al.
SPORTS MEDICINE (2000)
Share Paper
